Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
about
Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinicRecent Progress in Stem Cell Therapy for Diabetic NephropathyMesenchymal stem cells for the treatment of neurodegenerative and psychiatric disordersStem cell therapy to cure type 1 diabetes: from hype to hope.Trophic Factors from Tissue Stem Cells for Renal RegenerationFrom Beta cell replacement to beta cell regeneration: implications for antidiabetic therapyMesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes MellitusVascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promiseMesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal modelsMesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic NephropathyIntravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6Kidney-targeted transplantation of mesenchymal stem cells by ultrasound-targeted microbubble destruction promotes kidney repair in diabetic nephropathy ratsTracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles.β-Cell regeneration mediated by human bone marrow mesenchymal stem cells.Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus.Transplantation of human menstrual blood progenitor cells improves hyperglycemia by promoting endogenous progenitor differentiation in type 1 diabetic miceRepair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms.Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.Autografting of bone marrow mesenchymal stem cells alleviates streptozotocin‑induced diabetes in miniature pigs: real-time tracing with MRI in vivo.Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical studyStem cell-based cell therapy for glomerulonephritisThe antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells.Mesenchymal stem cell treatment for chronic renal failure.Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy.Diabetic nephropathy - complications and treatment.Cell-based therapies for diabetic complications.Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis.Stem cell-derived islet cells for transplantationThe TLR7 agonist Imiquimod promote the immunogenicity of mesenchymal stem cells.The use of biomaterials in islet transplantationCould cancer and infection be adverse effects of mesenchymal stromal cell therapy?Genetically modified mesenchymal stem cells for improved islet transplantationMetabolic and pancreatic effects of bone marrow mesenchymal stem cells transplantation in mice fed high-fat diet.Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates.Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus.The Role of Bone Marrow Cells in the Phenotypic Changes Associated with Diabetic NephropathyImmunogenicity of allogeneic mesenchymal stem cells transplanted via different routes in diabetic ratsRegenerative medicine as applied to general surgery
P2860
Q26739745-A4D95D4D-30B6-41B1-90FB-E2C6CF54C68EQ26740433-EEC20940-F319-45B6-A82F-509A438E7C38Q26801575-0E35832D-48D5-4972-8C34-4C1EBC5060ADQ26823294-86BDD9DC-7055-47B6-B3E8-03D40EFE1E66Q26829361-61A35BC3-7EDC-4AC2-A7F3-68CA0C8283ACQ26864024-61A8514F-D0AC-46FA-A082-03261974AE60Q26864580-9B8C69F3-9F58-425E-973B-612EBBA59264Q27026834-8E563F96-3288-4BAF-B49F-5EC754F958BFQ28085080-989F57B8-21BA-40FD-87E1-EFBE74D740FDQ28354224-9BCC5A4D-191E-4E5C-9947-B20771FCFAD3Q29620590-0B468250-C669-4ED2-9200-8C624AE241E2Q30453566-1EDCE921-BA6F-4696-B1E2-310341720D67Q30532793-C7070063-0843-4656-880E-9D5CC5C78BD5Q31081664-00DE6EB8-E489-438E-82FA-457F81FED012Q33403795-946DFAB9-D676-4C85-8A95-188F2EC0F053Q33637243-1E9B6FE1-B570-4E0F-BDC3-037A2561ADF6Q33713663-C4C7530A-619D-4B84-AB1E-463421753FA0Q33719419-367D8C23-D020-4E4B-8FBA-661BDE5AE9E6Q33747741-313A17CB-D2E1-497D-B2F5-C40F4833693FQ33767123-5C5F18E6-FA81-40D1-9A60-B559A7880AB2Q33805069-D7D12200-CF37-48A7-9048-D76759D55E2CQ33815233-6498CB22-AE1A-4A84-881F-936EA9C7CC08Q33900483-1DA3D78E-18E9-4EBE-A26E-76351C31B034Q33900615-E40A2412-1C2C-4A0D-9250-DCFC0782E39EQ34370097-447732C2-9FAD-494C-B7AF-FC8EDEBA9FF1Q34387952-0D1A3CB2-509D-4EA8-A3A2-B8C4D306699DQ35070554-EBDF5458-0413-4557-A065-75F2F746FE4CQ35124912-1BF13125-B6DA-4C7D-9FC2-0B6863BC1EA4Q35156849-5281F286-7159-410E-87AC-4CA27E6D02FEQ35186756-39BAEFFE-1334-4439-87C9-6FF208BA4353Q35196565-025E482A-70E3-480F-8FC9-2634D5BA3D40Q35205677-7697CB6A-E98F-410D-A180-CA1C07BAA2A4Q35256103-8AED0B38-B553-4A27-A1B0-15476027A725Q35552255-F590705E-2298-40B2-A3D2-0739CBBC04E3Q35609423-E396614D-E79A-4E95-9416-C9E7078EFD72Q35757109-3B0AE6A9-29E9-4639-982F-45EE586FACCFQ35763771-52983738-2C28-464A-BB0F-B572C07274ADQ35764838-27B3DC36-193E-4888-A7B5-F2DD7FA14DF0Q35833631-4D153417-2AFF-47F6-A4D1-33C1B88A3452Q35892487-0CE090C7-F201-46B1-8A36-EA64A2B4C5E8
P2860
Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Systemic administration of mul ...... pathy in type 1 diabetic mice.
@en
Systemic administration of mul ...... pathy in type 1 diabetic mice.
@nl
type
label
Systemic administration of mul ...... pathy in type 1 diabetic mice.
@en
Systemic administration of mul ...... pathy in type 1 diabetic mice.
@nl
prefLabel
Systemic administration of mul ...... pathy in type 1 diabetic mice.
@en
Systemic administration of mul ...... pathy in type 1 diabetic mice.
@nl
P2093
P1476
Systemic administration of mul ...... pathy in type 1 diabetic mice.
@en
P2093
Alejandro J Yañez
Daniel Carpio
Daniela B Parrau
Fernando E Ezquer
Marcelo E Ezquer
Paulette A Conget
P304
P356
10.1016/J.BBMT.2008.01.006
P577
2008-04-14T00:00:00Z